FDA — authorised 19 February 2002
- Marketing authorisation holder: SPECTRUM PHARMS
- Status: approved
FDA authorised Zevalin on 19 February 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 19 February 2002.
SPECTRUM PHARMS holds the US marketing authorisation.